Tune in to learn how QuartzBio’s Precision Medicine agentic framework, powered by proactive and prescriptive AI, is shortening trial timelines, improving regulatory adherence, and driving operational excellence across the R&D value chain. Our Sample Intelligence AI Agents monitor samples, detect emerging issues, automatically flag root causes, and deliver actionable, corrective guidance.
Join Tobi Guennel, Ph.D., QuartzBio’s Chief Technology Officer, at GenAI Roadmap: Transforming the Future of Healthcare & Life Sciences.
Join this webinar to unlock the speed you need with QuartzBio’s Precision Medicine AI Agents, which power our Biomarker and Sample Intelligence solutions by serving as secure, personalized assistants for stakeholders across the entire precision medicine value chain. They deliver 10x faster* insights within a unified, self-serve platform, amplifying the impact of every team member.
Learn how to use practical, conversational AI to amplify the power of your biomarker-rich clinical programs with QuartzBio’s Biomarker Intelligence Platform. You’ll discover QuartzBio’s approach, which employs smart, automated integration of biomarker, sample, and clinical data to create a unified data ecosystem — now amplified with the power of conversational interactions to enable more consumable insights.
QuartzBio is the only company purpose-built to deliver end-to-end Sample and Biomarker Intelligence for clinical-stage biopharma teams. Powered by a network of domain-specific AI agents, our solutions transform fragmented data into actionable intelligence, enabling conversational insights into your unified ecosystem of sample, clinical, and biomarker data.
QUARTZBIO® is a registered trademark of Precision Regulatory and Translational Sciences, Inc., dba QuartzBio, in the United States and/or other jurisdictions. All rights reserved.
© 2026. All rights reserved.
QuartzBio, Inc.
Privacy Policy | GDPR
Web Design and Development by RainCastle Communications.